Article Details
Retrieved on: 2021-05-25 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AVEO's earlier-stage pipeline includes monoclonal antibodies in oncology development, including AV-203 (anti-ErbB3 mAb) and AV-353 (anti-Notch ...
Article found on: www.valdostadailytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here